Beijing Bo Kang Gene Technology Co., Ltd. is located in Changping Park, Zhongguancun Science and technology park. It is a wholly-owned subsidiary of Hong Kong Liankang Biotechnology Group Co., Ltd. registered in China. Since 2002, when the original enterprise was acquired and taken over by the group, Bo Kangjian company has experienced a comprehensive business restructuring and technological upgrading. The company's business strategy is to ensure that the company's main product (voriconazole tablets), which is the best-selling product in the production and sales market, can generate normal income, while vigorously developing advanced biopharmaceutical technology. According to this strategy, our pharmaceutical R & D and production are carried out in two fields and two buildings respectively: Building 2 (biochemical building) is dedicated to biomedicine, especially the R & D and production of recombinant drugs; building 3 (preparation building) has set up process water preparation workshop, solid workshop (tablet, capsule and granule preparation), freeze-drying preparation workshop for serialization Beijing bokangjian Gene Technology Co., Ltd. is committed to become one of the backbone enterprises in China's biopharmaceutical industry.